ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals commercializes neffy, an epinephrine nasal spray for emergency treatment of anaphylaxis in adults and pediatric patients in the United States and Europe.
10-QNov 5Latest SEC filing
Nov 5Latest story
November 2026
August 2026
July 2026